DrugDashboards

Market view

dobutamine

9 marketed package NDCs · 4 active manufacturers

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other.

Same drug class

Other molecules FDA puts in beta-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dobutamine in shortage right now?
Yes. FDA currently lists Dobutamine in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Dobutamine?
4 companies have marketed Dobutamine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • Planned discontinuationDobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)Aug 27, 2025
  • In shortage nowDobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)Nov 6, 2017
  • In shortage nowDobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)Nov 6, 2017
  • In shortage nowDobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)Nov 6, 2017

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.